Skip to content
Wenlo
Sign in
← Markets

Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. (NBIX) — Form 144: Proposed sale of shares

144NBIXFiled Nov 2, 2026, 11:38 AM ET

About this filing

Neurocrine Biosciences, Inc. (NBIX) filed Form 144 (proposed sale of shares) with the SEC on Nov 2, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.

Key facts

Seller
GEORGE MORROW
Relationship
Director
Shares to sell
14,700
Market value
$2,147,670.00
Approximate sale date
Nov 2, 2026
Broker
Morgan Stanley Smith Barney LLC Executive Financial Services
Acquired
Nov 2, 2026 · Exercise of Stock Options

Rule 10b5-1 plan · adopted May 26, 2026

Remarks
  1. The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.

More NBIX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.